The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Mounjaro and Diabetes — How It Works in the UK
Mounjaro (tirzepatide) is a prescription-only injection that helps manage both type 2 diabetes and excess weight. It works differently from insulin by activating two natural hormone pathways (GIP and GLP-1) to regulate blood sugar and reduce appetite. Many people in the UK with type 2 diabetes are exploring Mounjaro as part of their weight management strategy. This guide explains how it works, who can access it, and what the evidence shows. Use our free GLP-1 weight loss calculator above to estimate potential weight loss with this medication.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
How Mounjaro Works for Type 2 Diabetes and Weight
Mounjaro's dual mechanism is key to understanding why it helps both diabetes control and weight loss. As a GIP and GLP-1 receptor agonist, it mimics two natural hormones released when you eat. This activates pathways in the brain that regulate appetite and blood sugar simultaneously. Unlike insulin, which directly lowers blood glucose, tirzepatide improves your body's own insulin response and may reduce how much glucose your pancreas needs to handle.
For type 2 diabetes specifically: Mounjaro helps your pancreas release insulin in response to food (only when needed), reduces how much sugar your liver produces, and slows gastric emptying so glucose enters your bloodstream more gradually. Weight loss follows because reduced appetite and slower gastric emptying mean you naturally eat less without feeling deprived.
- Activates GIP and GLP-1 hormone pathways
- Improves insulin sensitivity
- Reduces appetite and food cravings
- Slows digestion, prolonging feeling of fullness
- NOT insulin — does not directly inject glucose-lowering hormone
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
Mounjaro for Diabetes in the UK — Eligibility and Access
Mounjaro is not yet approved by NICE for type 2 diabetes management in the UK, though it is licensed for weight management. Many people with type 2 diabetes qualify for Mounjaro under weight management criteria if they have a BMI of 27 or above with a weight-related comorbidity (which includes diabetes itself). Use our free BMI calculator to check your personal BMI and understand your eligibility context.
Access in the UK comes through: NHS specialist tier 3/4 weight management services (via GP referral, though regional availability varies significantly); or private prescription following an online clinical assessment. If you have type 2 diabetes, your GP can discuss whether Mounjaro fits your treatment plan. The tirzepatide dose is started low (2.5 mg) and increased gradually over weeks — each dose requires at least 4 weeks before stepping up to allow your body to adapt.
Mounjaro for Diabetes in the UK — Eligibility and Access
Mounjaro is not yet approved by NICE for type 2 diabetes management in the UK, though it is licensed for weight management. Many people with type 2 diabetes qualify for Mounjaro under weight management criteria if they have a BMI of 27 or above with a weight-related comorbidity (which includes diabetes itself). Use our free BMI calculator to check your personal BMI and understand your eligibility context.
Access in the UK comes through: NHS specialist tier 3/4 weight management services (via GP referral, though regional availability varies significantly); or private prescription following an online clinical assessment. If you have type 2 diabetes, your GP can discuss whether Mounjaro fits your treatment plan. The tirzepatide dose is started low (2.5 mg) and increased gradually over weeks — each dose requires at least 4 weeks before stepping up to allow your body to adapt.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Can I use Mounjaro if I have type 2 diabetes?
Yes — Mounjaro is licensed for weight management, and type 2 diabetes is a qualifying weight-related health condition. Many UK adults with type 2 diabetes are eligible if their BMI is 27 or above. Your prescriber will assess whether it is clinically suitable alongside your other diabetes medications. Always inform them of all medications you take, as some diabetes drugs (like sulphonylureas) may need dose adjustment.
Does Mounjaro replace insulin or metformin?
No. Mounjaro works alongside your existing diabetes medications, not instead of them. It may eventually allow your prescriber to reduce doses of other medications (including insulin) if your blood sugar improves sufficiently — but this is a decision only your healthcare team can make. Never stop or reduce diabetes medications without guidance.
Is Mounjaro approved on the NHS for diabetes in the UK?
Mounjaro is currently approved on the NHS for weight management, not specifically for type 2 diabetes. However, NICE guidance is evolving. If you have type 2 diabetes and qualify for weight management treatment (BMI 27+ with comorbidities), you may access it via specialist services. Check with your GP about NHS availability in your region.
How quickly does Mounjaro improve blood sugar levels?
Blood sugar improvements typically begin within 1–2 weeks, though full benefit takes 4–8 weeks as your dose increases. Weight loss often follows more slowly — averaging 15–21% of body weight over 72 weeks in clinical trials. Individual results vary. Never adjust diabetes medications based on how you feel; always consult your GP or diabetes nurse.
What is tirzepatide and how does it differ from semaglutide (Ozempic/Wegovy)?
Tirzepatide (Mounjaro) is a dual GIP and GLP-1 agonist — it activates two hormone pathways. Semaglutide (Ozempic for diabetes, Wegovy for weight loss) activates only GLP-1. Clinical data suggests tirzepatide may produce slightly greater weight loss, but both are effective. Your prescriber will choose based on your individual health profile and availability.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.